SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001156175-17-000027
Filing Date
2017-10-06
Accepted
2017-10-06 16:14:47
Documents
1
Group Members
BROOKSIDE CAPITAL INVESTORS II, L.P.BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 IMMUNE DESIGN SCHEDULE 13G ImmuneInitial13G.txt SC 13G 10846
  Complete submission text file 0001156175-17-000027.txt   12605
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Public Equity Management, LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE
Type: SC 13G

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88256 | Film No.: 171127367
SIC: 2834 Pharmaceutical Preparations